The new Enron has been dismissed by many as a joke or a publicity stunt, but recent filings and a newly-revealed executive ...
The exposé led to the company’s CEO going to jail and to Anderson’s short-selling firm, Hindenburg Research, becoming one of ...
January 23, 2025) - Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) securities between November 2, 2023 and October 30, 2024, ...
CASE ALLEGATIONS: BioAge Labs is a clinical-stage biopharmaceutical company that develops therapeutic product candidates for metabolic diseases. In the IPO, BioAge Labs sold 12.65 million shares at ...
After four years as president, the Houston Texans are parting ways with Greg Grissom, who has been with the team since its inaugural season 25 years ago.
There’s a saying that opportunity follows policy. This is especially true in highly regulated industries where regulation ...
The issue dates back to 2014 when MSEDCL terminated the PPA with RGPPL over under supply of power from the plant ...
Treasury has released a 21-page proposal to merge the current standard-setting bodie s into one — a move that will abolish the current structures of the Financial Reporting Council, the Australian ...
Fundamental changes to market structures and risk profiles following deregulation of the world’s electricity markets have ...
Their biggest backers include an unlikely group of insurance companies, mutual funds and other usually conservative bond ...
In Slow Train Coming, he relates the tale of a life-affirming show from before its inception, through the recruitment of ...